
CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 985800-985976
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T30543","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T92805","span":{"begin":12,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Conclusion: The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T1987","span":{"begin":0,"end":176},"obj":"Epistemic_statement"}],"text":"Conclusion: The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T264","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T265","span":{"begin":12,"end":176},"obj":"Sentence"}],"text":"Conclusion: The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3029","span":{"begin":46,"end":49},"obj":"Body_part"}],"attributes":[{"id":"A3029","pred":"uberon_id","subj":"T3029","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"}],"text":"Conclusion: The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6105","span":{"begin":164,"end":166},"obj":"Disease"},{"id":"T80287","span":{"begin":164,"end":166},"obj":"Disease"}],"attributes":[{"id":"A6105","pred":"mondo_id","subj":"T6105","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A33190","pred":"mondo_id","subj":"T80287","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"Conclusion: The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}